Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • caswater
    Member
    • Jun 2011
    • 47

    question about exon usage across conditions?

    Hi,

    I want to quantify exon inclusion/skipping rates across a number of different conditions. So for each condition, I obtained FPKM values for each exon, and also FPKMs for each gene locus encompassing all the eons. Does it make sense if I use the ratio of EXON-FPKM/Gene-FPKM in each condition to quantify the exon usage in the condition?

    Thank you
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Yes, it seems logical to me.

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      So one notable problem with this approach is if you get a bit of a different mapping distribution between the groups (i.e., more/less 5' bias) then the results will be off. If you wanted to look at straight differential exon usage, you could just use DEXseq. If you wanted to specifically look at differential exon skipping, a good method would be (in this case, looking at skipping of exon #2):
      1. Count the number of reads mapping from exon 1 to exon 2
      2. Count the number of reads mapping from exon 1 to exon 3
      3. Fit these counts with a beta-binomial model (this is the same as is increasingly used to look at bisulfite sequencing and is the most relevant model for the type of data you have).


      There are a couple packages to do that with R, though I can't guarantee that they're pretty limited in terms of model complexity. If you need something that can handle more than 2 groups, just let me know, since I'm writing a package to do that (for methylation data, but the statistics are the same).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM
      • GATTACAT
        Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by GATTACAT
        Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
        07-01-2026, 11:43 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Working...